YFM backs Fishawack acquisition

Medical PR agency Fishawack Communications has made an acquisition in the US with backing from existing investor YFM.

YFM, which invested in the management buy-out of Fishawack two years ago, contributed an additional £600,000 from its Chandos Fund and British Smaller Companies VCT to support the purchase of Philadelphia-based Nexus Communications.

Oliver Dennis, principal founder of Fishawack, comments, ‘This is the logical next step for both businesses and gives Fishawack a strategically vital presence in the USA that will better equip the company to support its US-based clients.’

Michael White, investment director at YFM, says the move is ‘the first step in a buy-and-build strategy’ to create ‘the leading independent medical communications agency in the UK’.

Fishawack’s clients include GSK, Bio and Pfizer.

Nick Britton

Nick Britton

Nick was the Managing Editor for growthbusiness.co.uk when it was owned by Vitesse Media, before moving on to become Head of Investment Group and Editor at What Investment and thence to Head of Intermediary...

Related Topics